GTP cyclohydrolase I feedback regulatory protein (GFRP) mediates feedback inhibition of GTP cyclohydrolase I activity by tetrahydrobiopterin and also mediates the stimulatory effect of phenylalanine on the enzyme activity. To characterize the molecular structure of GFRP, we have purified it from rat liver using an efficient step of affinity chromatography and isolated cDNA clones, based on partial amino acid sequences of peptides derived from purified GFRP. Comparison between the amino acid sequence deduced from the cDNA and the N-terminal amino acid sequence of purified GFRP showed that the mature form of GFRP consists of 83 amino acid residues with a calculated M r of 9,542. The isolated GFRP cDNA was expressed in Escherichia coli as a fusion protein with six consecutive histidine residues at its N terminus. The fusion protein was affinitypurified and digested with thrombin to remove the histidine tag. The resulting recombinant GFRP showed kinetic properties similar to those of GFRP purified from rat liver. Cross-linking experiments using dimethyl suberimidate indicated that GFRP was a pentamer of 52 kDa. Sedimentation equilibrium measurements confirmed the pentameric structure of GFRP by giving an average M r of 49,734, which is 5 times the calculated molecular weight of the recombinant GFRP polypeptide. Based on the pentameric structure of GFRP, we have proposed a model for the quaternary structure of GFRP and GTP cyclohydrolase I complexes. 6, 7, 1 is an essential cofactor for aromatic amino-acid hydroxylases and nitric-oxide synthases (1, 2). The intracellular level of BH 4 is subsaturating for these enzyme reactions and thus is thought to be an important regulator of the activities of these enzymes. BH 4 is synthesized from GTP by a pathway composed of four enzyme reactions (1). Most important for regulation of BH 4 biosynthesis is GTP cyclohydrolase I (EC 3.5.4.16), which catalyzes the first and rate-limiting step of the conversion of GTP to dihydroneopterin triphosphate. GTP cyclohydrolase I is present in many organisms, ranging from bacteria to animal. In bacteria, this enzyme functions as the first enzyme in the biosynthesis of folic acid and not of BH 4 (1). Rat GTP cyclohydrolase I is composed of multiple identical subunits and shows positive cooperativity against GTP (3, 4).
GTP cyclohydrolase I feedback regulatory protein (GFRP) mediates feedback inhibition of GTP cyclohydrolase I activity by tetrahydrobiopterin and also mediates the stimulatory effect of phenylalanine on the enzyme activity. To characterize the molecular structure of GFRP, we have purified it from rat liver using an efficient step of affinity chromatography and isolated cDNA clones, based on partial amino acid sequences of peptides derived from purified GFRP. Comparison between the amino acid sequence deduced from the cDNA and the N-terminal amino acid sequence of purified GFRP showed that the mature form of GFRP consists of 83 amino acid residues with a calculated M r of 9,542. The isolated GFRP cDNA was expressed in Escherichia coli as a fusion protein with six consecutive histidine residues at its N terminus. The fusion protein was affinitypurified and digested with thrombin to remove the histidine tag. The resulting recombinant GFRP showed kinetic properties similar to those of GFRP purified from rat liver. Cross-linking experiments using dimethyl suberimidate indicated that GFRP was a pentamer of 52 kDa. Sedimentation equilibrium measurements confirmed the pentameric structure of GFRP by giving an average M r of 49,734, which is 5 times the calculated molecular weight of the recombinant GFRP polypeptide. Based on the pentameric structure of GFRP, we have proposed a model for the quaternary structure of GFRP and GTP cyclohydrolase I complexes.
(6R)-L-erythro-5,6,7,8-Tetrahydrobiopterin (BH 4 ) 1 is an essential cofactor for aromatic amino-acid hydroxylases and nitric-oxide synthases (1, 2) . The intracellular level of BH 4 is subsaturating for these enzyme reactions and thus is thought to be an important regulator of the activities of these enzymes. BH 4 is synthesized from GTP by a pathway composed of four enzyme reactions (1) . Most important for regulation of BH 4 biosynthesis is GTP cyclohydrolase I (EC 3.5.4.16), which catalyzes the first and rate-limiting step of the conversion of GTP to dihydroneopterin triphosphate. GTP cyclohydrolase I is present in many organisms, ranging from bacteria to animal. In bacteria, this enzyme functions as the first enzyme in the biosynthesis of folic acid and not of BH 4 (1) . Rat GTP cyclohydrolase I is composed of multiple identical subunits and shows positive cooperativity against GTP (3, 4) .
We have recently reported the identification of a new regulatory protein (GFRP) which mediates the feedback inhibition of GTP cyclohydrolase I by the end product of this pathway, BH 4 (5) . GFRP and BH 4 inhibit the enzyme activity of GTP cyclohydrolase I by decreasing its maximum velocity while having little effect on the affinity of GTP, indicating noncompetitive inhibition. GFRP exerts its inhibitory effect on GTP cyclohydrolase I by forming a complex with GTP cyclohydrolase I in the presence of BH 4 and GTP. Formation of the complex between the two proteins is reversible, depending on the presence of BH 4 and GTP. Furthermore, the inhibition of GTP cyclohydrolase I by GFRP and BH 4 is specifically reversed by L-phenylalanine. Phenylalanine is the substrate of phenylalanine hydroxylase, which requires BH 4 as a cofactor. Since the stimulatory effect of phenylalanine on GTP cyclohydrolase I activity results in an increase in the rate of BH 4 biosynthesis and, in turn, BH 4 is used for the conversion of phenylalanine to tyrosine, we suggest that this phenomenon be regarded as feed-forward regulation. Although phenylalanine reverses the GFRP-mediated inhibitory effect of BH 4 on GTP cyclohydrolase I, the protein complex remains intact in the presence of GTP, BH 4 , and phenylalanine. Furthermore, phenylalanine alone induces complex formation between GFRP and GTP cyclohydrolase I, and under these conditions, GTP cyclohydrolase I, which shows positive cooperativity against GTP (3), changes its kinetic behavior from sigmoidal to hyperbolic.
The discovery of GFRP and its function related to phenylalanine revealed the molecular mechanism of a mysterious clinical observation that, in patients with phenylketonuria, the plasma levels of biopterin are increased as are those of phenylalanine (6 -9) . Thus, the high levels of phenylalanine, which accumulate due to a deficiency of phenylalanine hydroxylase, continuously stimulate the rate of BH 4 biosynthesis by the stimulatory effect on GTP cyclohydrolase I activity mediated via GFRP. If this mechanism also operates in cells producing catecholamines or nitric oxide, phenylalanine should affect the biosynthesis of these biologically active molecules by regulating the biosynthesis of the rate-limiting cofactor BH 4 . Thus, GFRP also may be important in these cells.
As a first step toward elucidating the molecular mechanism of GFRP action, we have established procedures for the purification, cDNA cloning, and bacterial expression of GFRP. These procedures and the characterization of the subunit structures of GFRP are presented here. In particular, the information on the quaternary structure of GFRP provides important insights into the mechanism of GFRP-mediated GTP cyclohydrolase I regulation. Another method for purifying and cloning GFRP was recently reported by Milstien et al. (10) . These authors proposed naming the protein GTP cyclohydrolase I feedback regulatory protein (GFRP), a name that is similar to feedback regulator protein for GTP cyclohydrolase I, which we originally designated the protein (5) . This suggested terminology is adopted here.
EXPERIMENTAL PROCEDURES
Materials-GTP was obtained from Yamasa (Chiba, Japan). BH 4 was a generous gift from the Suntory Institute for Medicinal Research and Development (Gunma, Japan). [␣-32 P]dCTP was from Amersham Corp. Dimethyl suberimidate was from Pierce.
Assay of GTP Cyclohydrolase I Activity-GTP cyclohydrolase I activity was assayed as described (3) . Briefly, the standard reaction mixture contained 50 mM Tris-HCl (pH 7.2 at 37°C), 100 mM KCl, 1 mM EDTA, 1 mM DTT, 0.2 mM GTP, the enzyme, GFRP, and BH 4 and/or phenylalanine. The recombinant rat GTP cyclohydrolase I obtained from the plasmid construct described below was used for the assay and had the same enzymatic properties as GTP cyclohydrolase I purified from rat liver. 2 The reaction was carried out at 37°C for 15 min. Then the reaction product, dihydroneopterin triphosphate, was converted to neopterin triphosphate by oxidation with I 2 and KI and then dephosphorylated to neopterin by alkaline phosphatase. Finally, neopterin was quantitated by HPLC and fluorescence detection (3) .
Protein Determination-The concentration of protein was determined using a Bio-Rad dye-binding protein assay kit with bovine ␥-globulin as a standard (11) .
Construction of Recombinant GTP Cyclohydrolase I and Preparation of Bacterial Lysates-The maltose-binding protein (MBP) vector system (12) was used for the bacterial expression of rat GTP cyclohydrolase I. The NcoI recognition sequence is located around the initiation codon of rat GTP cyclohydrolase I cDNA (4) . The plasmid harboring the cDNA (pRGC) was digested with NcoI and then further digested with mung bean nuclease to create a blunt end. Then the plasmid was further digested with HindIII, and the resulting NcoI (blunted)-HindIII fragment was cloned between the SmaI and HindIII sites of a pMALc vector (New England Biolabs Inc.) to generate pMAL-RGC. The pMAL-RGC plasmid contained the entire coding region of GTP cyclohydrolase I except for the initiator methionine, located just after the sequence coding Ile-Glu-Gly-Arg (factor Xa cleavage site), which was attached to the C terminus of MBP.
Escherichia coli strain JM109 containing pMAL-RGC was cultured overnight at 37°C. The 5-ml culture was used to inoculate 1 liter of rich medium (New England Biolabs Inc.), which was incubated until A 600 reached 0.5. Isopropyl-␤-D-thiogalactopyranoside was added at a concentration of 0.6 mM, and the E. coli culture was incubated for an additional 3 h. The bacterial cells were harvested by centrifugation and stored at Ϫ70°C. Half of the bacterial pellet was thawed on ice and sonicated in 10 ml of lysis buffer containing 10 mM sodium phosphate (pH 7), 30 mM NaCl, 0.25% Tween 20, 10 mM EDTA, 10 mM EGTA, 10 mM ␤-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride, 0.5 g/ml leupeptin, and 0.72 g/ml pepstatin. The lysate was centrifuged at 14,000 rpm for 10 min. The supernatant solution was recovered, and the precipitate was sonicated again in 2 ml of lysis buffer and centrifuged. The supernatants were combined, and the lysate was divided into four parts (each 3 ml) and stored at Ϫ70°C.
Purification of GFRP-All procedures were done at 4°C unless otherwise stated. Frozen rat livers (120 g) obtained from male Wistar rats were homogenized in 480 ml of 10 mM Tris-HCl (pH 7.8 at 1 M), 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride, 0.5 g/ml leupeptin, 0.35 g/ml pepstatin, and 1 g/ml E-64 (N-[N-(L-3-trans-carboxirane-2-carbonyl)-L-leucyl]agmatine; Boehringer Mannheim) by an Ultra-Turrax homogenizer. The homogenate was centrifuged successively at 8,000 rpm for 20 min and then at 42,000 rpm for 1 h to obtain the supernatant solution. The solution was applied to a 250-ml column of DEAE-Toyopearl (Tosoh, Tokyo, Japan) equilibrated with 10 mM Tris-HCl, 1 mM EDTA, and 1 mM EGTA at a flow rate of 400 ml/h. The column was washed with 400 ml of the homogenization buffer and then eluted with the buffer containing 0.15 M NaCl. The 120-ml eluate was divided into two parts and stored at Ϫ70°C until use.
The frozen DEAE-Toyopearl eluate was thawed on ice, and the following solution was successively added to the eluate while stirring: 1.2 ml of 0.5 M sodium phosphate buffer (pH 7.2), 0.6 ml of 25% Tween 20, 3 ml of the E. coli lysate containing the MBP-GTP cyclohydrolase I fusion protein, 65 l of 1 M DTT, 130 l of GTP, and 13 l of 0.1 M BH 4 . The 67-ml solution was mixed with 14.2 ml of the amylose column equilibration buffer (described below) containing 2 M NaCl. Then the solution was applied to a 15-ml column of amylose (New England Biolabs Inc.) equilibrated with an equilibration buffer of 10 mM sodium phosphate (pH 7.2), 500 mM NaCl, 0.22% Tween 20, 1 mM EGTA, 1 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride, 0.2 mM GTP, and 20 M BH 4 (buffer A). The column was washed with 25 ml of buffer A and then with 50 ml of buffer A without Tween 20 and eluted with buffer A containing 10 mM maltose and no Tween 20. The eluate was concentrated to 1.7 ml by ultrafiltration (Amicon Centriflow CF-25).
The following column operations were done at room temperature. The concentrated solution was applied to a Superose 6 column (1.6 ϫ 47 cm; Pharmacia Biotech Inc.) equilibrated with TKE buffer (50 mM Tris-HCl (pH 7.5), 100 mM KCl, and 1 mM EDTA) containing 1 mM DTT, 0.1 mM GTP, and 20 M BH 4 at a flow rate of 1 ml/min. The fractions containing the complex between GFRP and GTP cyclohydrolase I were combined and concentrated to 0.5 ml by ultrafiltration. The concentrated solution was filtered through a Sephadex G-25 HR10/10 column (Pharmacia) equilibrated with TKE buffer containing 1 mM DTT and 0.01% Triton X-100 (Boehringer Mannheim) at a flow rate of 2 ml/min. The 1.5-ml eluate was applied at a flow rate of 1 ml/min to the Superose 6 column equilibrated with the same buffer as that used for Sephadex G-25. The second smaller peak, which eluted after a larger peak of the MBP-GTP cyclohydrolase I fusion protein, was collected (see Fig. 1A ). The fractions were combined and concentrated to 0.4 ml by ultrafiltration. To verify the homogeneity of the purified preparation of GFRP, 0.1 ml of the final sample was analyzed by DEAE-nonporous resin (Tosoh) HPLC. The column, run at a flow rate of 1 ml/min, was washed with 4 ml of 10 mM Tris-HCl (pH 8), 20 mM KCl, and 0.1 mM EDTA and then eluted with a 10-ml linear gradient of KCl in the equilibration buffer. The single protein peak that eluted at a KCl concentration of 0.17 M was collected (see Fig. 1B ).
SDS-Polyacrylamide Gel Electrophoresis-SDS-polyacrylamide gel electrophoresis was performed using the PhastSystem (Pharmacia). After electrophoresis, protein was stained with Coomassie Brilliant Blue.
Determination of Partial Amino Acid Sequences of GFRP-A sample of purified GFRP (3 g) was directly subjected to amino acid sequencing using an Applied Biosystems Model 470A automated gas-phase protein sequencer equipped with an on-line HPLC apparatus (Model 120A). The purified GFRP (7 g) also was digested with lysyl endopeptidase (4 pmol; Wako Chemicals, Osaka, Japan) in a solution (150 l) containing 50 mM Tris-HCl (pH 9.5), 2 M guanidine HCl, and 1 mM DTT at 30°C for 21 h. The digest was injected onto an ODS column (4.6 ϫ 250 mm; Nacalai Tesque Inc., Kyoto, Japan) and separated with a 100-ml gradient of acetonitrile from 5 to 60% in 0.1% trifluoroacetic acid at a flow rate of 1 ml/min. The eluate was monitored at 220 nm, and the peak fractions were collected and subjected to amino acid sequence analysis.
cDNA Cloning of GFRP-From the N-terminal and peptide amino acid sequences of GFRP, we designed two sets of mixtures of oligonucleotide primers that cover all possible codons for each amino acid. One set (primers 1 and 3) was used for the first PCR, and the other set (primers 2 and 4) was used for a second, nested PCR (see Fig. 2 ). From 10 g of rat liver poly(A) ϩ RNA as a template, first strand cDNA was synthesized from primer 3 (2.5 M) by Moloney murine leukemia virus reverse transcriptase (200 units). Out of a total of 20 l, 1 l of the resulting cDNA was PCR-amplified in a 100-l reaction using primers 1 (3 M) and 3 (1 M). The PCR conditions were 1 min of denaturation at 94°C, 2 min of annealing at 48°C, and 1 min of extension at 72°C for 30 cycles. The amplified products were separated on 3% Nusieve agarose GTG (FMC Corp.), and DNA products between 100 and 200 bp in size were isolated because the expected length of cDNA fell in this range. Using the first PCR product as a template, we performed the second PCR with primers 2 (1 M) and 4 (1 M) under the same PCR conditions as described above. The amplified ϳ130-bp band was iso- 2 Details of the purification and characterization of the recombinant GTP cyclohydrolase I will be published elsewhere (K. Hatakeyama, and T. Yoneyama, manuscript in preparation). lated and then subcloned into a pCRII vector (Invitrogen). Both strands of the inserts were sequenced using an ABI PRISM 377 DNA sequencer.
From the sequence of the GFRP cDNA isolated above, two primers (primers 5-1 and 5-2) were designed for performing 5Ј-RACE (13) (see Fig. 2 ). We used the 5Ј-AmpliFINDER RACE kit (CLONTECH) following the manufacturer's instructions. Primer 5-1 was used for cDNA synthesis, and primer 5-2 was used for PCR amplification with an anchor primer (CLONTECH). The PCR products were digested with EcoRI and BamHI and then cloned into a pBluescript SK Ϫ vector (Stratagene) between the EcoRI and BamHI sites.
From the sequence of the GFRP cDNA isolated using mixed primers, two other primers (primers 3-1 and 3-2) were designed for performing 3Ј-RACE (13) (see Fig. 2 ). We used the 3Ј-RACE system (Life Technologies, Inc.). First cDNA strand was synthesized with an adapter primer (Life Technologies, Inc.). Then the first PCR was carried out with primer 3-1 and a universal adapter primer (Life Technologies, Inc.). The PCR products were separated on a gel, and products between 0.2 and 1.0 kilobase pair were isolated. Using the isolated PCR products as a template, the second PCR was carried out with primer 3-2 and the universal adapter primer, and the major products were isolated and cloned into a pCRII vector.
Bacterial Expression and Purification of Recombinant GFRP-Two PCR primers were designed to construct a pET expression vector (14) for GFRP. The E-1 primer was a 36-mer (5Ј-GGGAATTCCATATGCCT-TACCTGCTCATCAGCACTC-3Ј), which contained an NdeI site (underlined) covering the ATG translation start codon of GFRP. The E-2 primer was a 39-mer (5Ј-GGGAATTCGTCGACAGGTCATTCCTTGT-GCAGACACCAC-3Ј), which contained a SalI site (underlined) 3 bp downstream of the TGA translation stop codon. The PCR products obtained with the E-1 and E-2 primers were separated on a gel, and the major 230-bp band was isolated. After digestion with NdeI and SalI, the fragment was cloned into plasmid pET-15b (Novagen) between the NdeI and XhoI sites. The resulting construct encoded a stretch of six histidine residues (His 6 tag) followed by the complete coding region of GFRP.
E. coli strain BL21(DE3) transformed with the His 6 -GFRP construct (pET-His 6 -GFRP) was induced with isopropyl-␤-D-thiogalactopyranoside for 4 h, harvested, and frozen. The cells obtained from a 225-ml culture were sonicated in 6 ml of lysis buffer containing 20 mM Tris-HCl (pH 7.9), 0.3 M NaCl, 40 mM imidazole, 0.25% Tween 20, 5 mM ␤-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride, and 0.72 g/ml pepstatin, and insoluble materials were removed by centrifugation. The supernatant solution was loaded onto a 1-ml nickel-nitrilotriacetic acid column (QIAGEN Inc.) equilibrated with lysis buffer and washed with lysis buffer and then with an elution solution of 20 mM potassium phosphate (pH 5.9), 0.3 M NaCl, and 5 mM ␤-mercaptoethanol containing 20 mM imidazole. The His 6 -GFRP fusion protein was then eluted from the column with the elution solution containing 0.5 M imidazole. The eluate was concentrated by ultrafiltration (Amicon Centriflow CF-25) and filtered through a Sephadex G-25 HR10/10 column equilibrated with 0.1 M sodium phosphate (pH 6.5).
Isolation of His 6 Tag-free GFRP-To remove the N-terminal histidine residues of the purified His 6 -GFRP fusion protein, the protein was digested with thrombin, which cleaves at its recognition sequence (LeuVal-Pro-Arg-Gly-Ser) located between the His 6 tag and GFRP. Thrombin cleaves peptides at the carboxylic side of the arginine residue. Ten mg of the protein was digested with 6.6 units of thrombin (Boehringer Mannheim) in 2.77 ml of 100 mM sodium phosphate buffer (pH 6.5) containing 2.5 mM CaCl 2 at room temperature for 4 days. After the addition of 30 l of 0.5 M EDTA, insoluble materials were removed by centrifugation. The supernatant was concentrated to 1.3 ml by ultrafiltration (Amicon Centriflow CF-25). Aliquots (200 l) of the concentrated solution were separated on a Superdex 75 HR column (1 ϫ 30 cm; Pharmacia) equilibrated with 20 mM Hepes-KOH (pH 7.5), 0.2 M KCl, and 1 mM EDTA at a flow rate of 0.5 ml/min.
Cross-linking of GFRP-Cross-linking reactions were performed in 100 l of 50 mM Hepes-KOH buffer (pH 8.2) containing 0.2 M KCl, 1 mM EDTA, and 1 mM DTT or 0.2 M triethanolamine HCl buffer (pH 8 or 9) containing 0.1 mM DTT at a GFRP subunit concentration of 2 or 20 M. The reaction mixture was prepared on ice. To the mixture was added freshly prepared dimethyl suberimidate to concentrations varying from 0.2 to 25 mM. The resulting mixture was incubated at room temperature for 10 min or 1.5 h, and the reaction was quenched by the addition of 1 M lysine. Protein was then precipitated using a deoxycholate/ Cl 3 CCOOH procedure (15) . The precipitates were washed with ethyl ether to remove Cl 3 CCOOH and dissolved in electrophoresis sample buffer. Cross-linked protein was resolved by electrophoresis on 10% (w/v) polyacrylamide gels in the presence of SDS as described by Weber and Osborn (16) . After electrophoresis, protein was stained with silver (17) .
Sedimentation Equilibrium of GFRP-Sedimentation equilibrium measurements were carried out using a Beckman Instruments Optima™ XLA analytical ultracentrifuge. The data were fit using the Origins™ software supplied with the instrument (18) . For the fitting, we calculated the molar extinction coefficient and partial specific volume from the composition of recombinant GFRP using the residue values of Perkins (19) ; these were 11,237 M Ϫ1 cm Ϫ1 and 0.739 cm 3 /g, respectively. The sedimentation equilibrium experiment utilized three double sector cells and was carried out at three protein concentrations (8, 16 , and 24 M initially), a rotor speed of 16,000 rpm, and 20°C. In each cell, 100 l of protein solution and 110 l of buffer (20 mM Hepes-KOH, 0.1 M KCl, and 1 mM EDTA (pH 7.6)) were loaded. The data were collected after 24 h. Corrections for the density of the solvent were based on a value of 1.006 g/ml, calculated from values provided in Ref. 20 .
RESULTS AND DISCUSSION

Purification, cDNA Cloning, and Bacterial Expression of Rat GTP Cyclohydrolase I Feedback Regulatory Protein
Purification of GFRP-We affinity-purified GFRP from rat liver by utilizing the fact that it forms a complex with GTP cyclohydrolase I in the presence of GTP and BH 4 and dissociates from the complex in the absence of GTP and BH 4 (5). Because GFRP also inhibited the activity of a recombinant form of GTP cyclohydrolase I fused to MBP in the presence of BH 4 , we inferred that GFRP also formed a complex with the MBP-GTP cyclohydrolase I fusion protein. As described under "Experimental Procedures," partially purified rat liver extracts were mixed with E. coli lysate containing the MBP-GTP cyclohydrolase I fusion protein, and then the mixture was supplemented with GTP and BH 4 . When the mixture was applied to an amylose column, all the enzyme activity and the inhibitory activity were bound to the amylose. Thus, GFRP appeared to bind to the GTP cyclohydrolase I fusion protein, which in turn was bound to amylose through its MBP portion. Since the amylose fraction also contained endogenous E. coli MBP, the fraction was filtered through Superose gel equilibrated with a buffer containing GTP and BH 4 to separate the complex from E. coli MBP. The isolated complex of GFRP and the MBP-GTP cyclohydrolase I fusion protein was then filtered through Superose gel equilibrated with a buffer containing neither GTP nor BH 4 to separate GFRP from the MBP-GTP cyclohydrolase I fusion protein. As shown in Fig. 1A , a small protein peak was eluted from the column at an elution volume (80 ml) corresponding to an apparent molecular mass of 35 kDa. The peak contained a BH 4 -dependent inhibitory activity against GTP cyclohydrolase I. When the preparation was analyzed by SDSpolyacrylamide gel electrophoresis, a single band was observed (data not shown). To further verify the homogeneity of the preparation, it was analyzed on a DEAE-nonporous resin HPLC column (Fig. 1B) . A single peak was eluted from the DEAE column. The flow-through fraction showed absorbance at 280 nm, but did not contain any protein. The fraction from the single peak contained a BH 4 -dependent inhibitory activity against GTP cyclohydrolase I as shown by enzyme assay and also contained a protein that migrated on SDS gel at the same position as that observed using the Superose fractions. The overall purification of GFRP is summarized in Table I . Thus, an ϳ35,000-fold purification in the specific activity of GFRP from rat liver extract was achieved with a yield of 30%.
The subunit molecular mass of GFRP was estimated to be 9.4 kDa by SDS gel analysis, while the apparent native molecular mass of GFRP from gel filtration data was 35 kDa. In addition, a single amino acid (proline) was identified as the N-terminal residue for the purified preparation of GFRP as described below. Therefore, we conclude that GFRP is a protein consisting of multiple identical subunits.
The purified preparation of GFRP had the same effect on the kinetic properties of GTP cyclohydrolase I as we reported using partially purified GFRP (5), as shown in Fig. 3 . The activity of GTP cyclohydrolase I was inhibited in the presence of GFRP in a BH 4 dose-dependent manner, and the median effective concentration of BH 4 was 2 M (Fig. 3A) . The inhibition of GTP cyclohydrolase I by GFRP at a BH 4 concentration of 7 M was dose-dependently reversed by phenylalanine (Fig. 3B) . In the presence of phenylalanine and in the absence of BH 4 , the substrate velocity curve for GTP cyclohydrolase I activity changed from a sigmoidal form to a hyperbolic form in the presence of GFRP (Fig. 3C) . The Hill coefficient decreased from 2.4 to 1.2 in 1 mM phenylalanine.
Partial Amino Acid Sequencing and cDNA Cloning of GFRP-To determine the primary structure of and to establish a bacterial expression system for GFRP, we cloned a cDNA encoding GFRP. The N-terminal amino acid sequence was determined from a purified preparation of GFRP to be Pro-TyrLeu-Leu-Ile-Xaa-Xaa-Gln-Ile-Xaa-Met (Xaa represents unidentified residues). Then purified GFRP was digested by lysyl endopeptidase, and four fractions were isolated and sequenced. Fraction L3 gave no amino acid sequence. The amino acid sequences obtained from fractions L1, L2, and L4 are shown in Fig. 2 . By comparison with sequences from the N terminus of GFRP, it was deduced that the L2 peptide was derived from the N terminus.
Considering the expected paucity of GFRP in rat liver and its relatively low molecular weight (5), we undertook to clone its cDNA by reverse transcription-PCR techniques. Fig. 2 shows the primers used for cloning and the determined nucleotide sequence. The sequence of the longest of eight 5Ј-RACE clones isolated is shown in Fig. 2 . Two other clones were just 15 bp shorter than the longest clone, probably because the additional 15-bp region is GC-rich and reverse transcriptase might not go through it. In the eight clones sequenced, bases C and T were found equally in number for the nucleotide located 150-bp downstream from the first nucleotide of the ATG translation start codon (given as T in Fig. 2 ). Either base that is in the third codon encodes asparagine, and the nucleotide variation is probably due to genetic heterogeneity of the rat and not to PCR misincorporation. Among six 3Ј-RACE clones isolated and sequenced, the longest four were connected to the poly(A) tail at the same site. The whole sequence shown in Fig. 2 contains 676 nucleotides, including a poly(A) tail. When compared with the recently reported nucleotide sequence (10), our sequence differed in three positions. Base A was identified instead of G at position Ϫ42 from the first nucleotide of the ATG translation start codon, and the sequence GA instead of CT at positions Ϫ50 and Ϫ49. Moreover, the sequence presented here contains an additional 17 nucleotides in the 5Ј-untranslated region.
Deduced Amino Acid Sequence of GFRP-The open reading frame encodes 84 amino acid residues. All of the peptide sequences obtained from purified GFRP were found in the translated cDNA sequence (Fig. 2) . The deduced amino acid sequence is the same as that reported (10) . Comparison of the amino acid sequence deduced from the nucleotide sequence and that determined by Edman degradation from purified GFRP revealed that the initial methionine was missing in purified GFRP. Thus, the mature form of GFRP was inferred to consist of 83 amino acid residues with a calculated M r of 9,542, similar to the value of 9,400 determined by SDS-polyacrylamide gel electrophoresis for the purified sample. In addition, the se- a The activity of GFRP is expressed as the amount of GTP cyclohydrolase I activity that was inhibited. b The protein concentration was estimated by absorbance at 280 nm, assuming 1 A unit represents 1 mg/ml protein.
quence contained three possible phosphorylation sites that coincided with the amino acid sequence motifs proposed for kinases (21) Bacterial Expression and Purification of GFRP-To obtain a large amount of GFRP for structural and functional characterization, we constructed a bacterial expression vector (pET-15b) to connect a stretch of six histidine residues at the N terminus of GFRP and purified the His 6 -GFRP fusion protein using a nickel-nitrilotriacetic acid column. The purified His 6 -GFRP fusion protein was digested with thrombin to remove the His 6 tag from GFRP. The final preparation of recombinant rat GFRP thus obtained contains four additional amino acid residues (Gly-Ser-His-Met) at the N-terminal proline of native GFRP. Recombinant GFRP showed kinetic effects on the enzyme activity of GTP cyclohydrolase I identical to those shown in Fig.  3 for the GFRP preparation purified from rat liver (data not shown). These data provide definitive evidence that the isolated cDNA encoded GFRP and that recombinant GFRP is functionally active, with features indistinguishable from native GFRP, although it contained four additional amino acid residues at its N terminus. This bacterial expression system yielded ϳ30 mg of protein from a 1-liter culture of E. coli. We used His 6 -free recombinant GFRP for further experiments.
Subunit Composition of GTP Cyclohydrolase I Feedback Regulatory Protein
Cross-linking of GFRP-To determine the number of subunits in GFRP, we performed cross-linking experiments using the bifunctional reagent dimethyl suberimidate. The sizes of the products were estimated by the mobilities of the crosslinked proteins as determined by SDS-polyacrylamide gel electrophoresis (22) . Fig. 4A shows the typical result of reacting 20 M GFRP with 3 mM dimethyl suberimidate in a Hepes buffer at room temperature for 1.5 h. Five bands of decreasing intensity and increasing molecular mass were observed. As shown in Fig. 4B , the cross-linking reaction proceeded further in a triethanolamine buffer. The degree of cross-linking was lesser at a shorter incubation time of 10 min or at lower concentrations of dimethyl suberimidate (data not shown). The pattern of cross-linking was independent of the concentration of dimethyl suberimidate in the range of 1-25 mM. Thus, the reaction conditions appeared to be saturated with respect to the efficiency of cross-linking with this reagent. Furthermore, as dimethyl suberimidate is short-lived because of its high reactivity with water, dimethyl suberimidate was added to the reaction mixture every 30 min during the 1.5-h reaction in an attempt to improve cross-linking efficiency, but similar results were obtained.
The five bands observed were of decreasing intensity and increasing molecular mass. The extensiveness of cross-linking of GFRP is probably limited by the fact that there are only three lysine residues/GFRP subunit (Fig. 2) .
When cross-linking was performed at a lower GFRP concentration of 2 M (Fig. 4A, lane 2) , the relative yields of the protein species were similar to those at 20 M. The crosslinking reaction was thus insensitive to concentration of the protein. This finding indicates that the reaction occurs within GFRP oligomers and not between GFRP oligomers.
By comparison with the relative mobilities of standard marker proteins, the molecular masses of the proteins in the five stained bands were estimated to be approximately 9.7, 21.8, 31, 43, and 52 kDa (Fig. 4C) . These molecular masses correlate well with the predicted values of monomer, dimer, trimer, tetramer, and pentamer of the recombinant GFRP polypeptide chain of 9,954 Da. We therefore conclude that GFRP is a pentamer.
Sedimentation Analysis of GFRP-To further confirm our conclusion, we performed sedimentation equilibrium measurements (Fig. 5) . The data from three cells gave good fits, assuming a single thermodynamically ideal species, to an average M r of 49,734, with a standard deviation of the calculated molecular weights in the three cells of Ϯ2.7%. There was no dependence of the calculated molecular weight upon initial protein concentration. Calculations of molecular weight versus absorbance at 280 nm (18) showed no tendency toward dissociation or aggregation. The measured average molecular weight is 5.0 times that of the subunit, so we conclude that the solution form of GFRP is a stable pentamer.
Gel Filtration Analysis of GFRP-Both the purified preparation of GFRP from rat liver and that of recombinant GFRP eluted from a Superdex 75 column at a position corresponding to a molecular mass of 35 kDa (Fig. 6A) . The eluting position is the same as the one we observed using crude extracts from rat liver (5) . The elution position of GFRP on the Superdex 75 column was not different in the range of the pH of the equilibration buffer from 6 to 9: Mes-KOH buffer was used for pH 6 and 7; Hepes-KOH buffer for pH 7 and 8; and Tris-HCl for pH 7, 8, and 9. No significant difference in the behavior of GFRP also was observed between the equilibration buffers containing 0.1 M and 0.2 M KCl or for buffers with or without 5% glycerol. There was no dependence of the elution position and recovery of GFRP on the amount of protein injected ranging from 1 to 50 g.
A different group recently reported that GFRP eluted from tandemly linked columns of Superose 6 and Zorbax GF-250 at a position corresponding to a molecular mass of 20 kDa (10). These investigators suggested that the higher molecular mass of GFRP that we had observed (5) using crude rat liver extracts was due to a slow dissociation of GFRP from GTP cyclohydrolase I during the column operation. However, this explanation is unlikely because the eluted peak of BH 4 -dependent inhibitory activity (GFRP) was symmetrical, and no such activity was detected between the fractions containing GTP cyclohydrolase I activity and those containing GFRP (5). The present result using the purified preparation of GFRP further confirmed that GFRP behaved as a 35-kDa protein on Superdex 75.
GFRP behaved as a 35-kDa protein on a Superose 6 column as well as on a Superdex 75 column (5) . Therefore, we inferred that the silica-based column of Zorbax GF-250 was the cause of the slower migration of GFRP. As predicted, recombinant GFRP eluted from a TSK G3000SW XL column (Tosoh), another silica-based column, at a position corresponding to a molecular Elution was performed at a flow rate of 0.5 ml/min for Superdex 75 and 1 ml/min for G3000SW XL at room temperature. Elution profiles and plots of elution volumes against log(molecular mass) are shown (A2 and B2). The molecular mass markers used were bovine ␥-globulin (160 kDa) (Bio-Rad), bovine serum albumin (66 kDa), hen egg white ovalbumin (45 kDa), bovine carbonic anhydrase (29 kDa), and bovine ribonuclease A (13.7 kDa) (Sigma). mass of 17 kDa (Fig. 6B) .
The fact that the elution position of GFRP relative to the marker proteins from the silica-based resins was later than that from the agarose-based resins suggests the adsorption of GFRP to the silica-based resins. The relative molecular mass of GFRP estimated by gel filtration on the agarose-based resins was still lower than those determined by cross-linking and sedimentation equilibrium experiments. GFRP also may interact with the agarose-based resins. Alternatively, the anomalous behavior of GFRP may reflect a more compact conformation, lower hydration, or both of GFRP relative to ovalbumin and carbonic anhydrase (23) .
Conclusions
From the data presented, GFRP is inferred to be a protein of 83 amino acids that is produced by deletion of the initial methionine residue of the primary translated peptide. Recombinant GFRP produced in E. coli, which contains four additional amino acid residues at the N terminus, is indistinguishable from native GFRP in terms of its effect on GTP cyclohydrolase I activity and its behavior on gel filtration. Cross-linking and sedimentation equilibrium experiments indicate that GFRP is a pentamer of identical subunits. The observation that GFRP is a pentamer prompts us to speculate on the structure of the complexes formed between GFRP and GTP cyclohydrolase I. Our current hypothesis regarding the mechanism of GFRP action is based on the results of our previous work (5) and this work, as depicted in Fig. 7 . By supposing a general symmetrical structure of protein complexes, we hypothesize that one subunit of GFRP interacts with one subunit of GTP cyclohydrolase I. As GTP cyclohydrolase I is probably an oligomer consisting of 10 subunits (3, 4) , this suggests that two pentamers of GFRP interact with one decamer of GTP cyclohydrolase I. Consistent with this hypothesis is the recent crystallographic evidence that E. coli GTP cyclohydrolase I is a decamer formed by face-to-face association of two pentamers (24) . The considerable sequence similarity between E. coli (25) and rat (4) GTP cyclohydrolases I suggests that rat GTP cyclohydrolase I has a three-dimensional structure similar to that of the bacterial enzyme. This possibility is currently under investigation in our laboratory. FIG. 7 . Models for GFRP-mediated regulation of GTP cyclohydrolase I. Shown schematically are modes of complex formation between GFRP and GTP cyclohydrolase I. For clarity, the possible different conformational states of GFRP and GTP cyclohydrolase I are not indicated. Free GTP cyclohydrolase I is active and shows positive cooperativity toward GTP. GFRP changes the enzyme kinetics from sigmoidal to hyperbolic in a phenylalanine-dependent manner through formation of a complex with the enzyme. Alternatively, GFRP stabilizes the conformation of a kinetically inactive enzyme in a BH 4 -dependent manner by forming a complex with the enzyme. In both cases, a GFRP pentamer binds to each of the outer faces of two pentamers of GTP cyclohydrolase I, which are associated face-to-face. Thus, GTP cyclohydrolase I is sandwiched between GFRPs. The binding sites for GTP, BH 4 , and phenylalanine remain to be determined.
